FDA Investigator Stanley Au
Stanley Au has conducted inspections on 6 sites in 2 countries as of 29 Jul 2019. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
29 Jul 2019
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Canada
FDA Investigators that have inspected at least one site in common with Stanley Au:
Amalia C Himaya,
Amanda E Lewin, PhD,
Angela Shepas,
Anita Narula, PhD,
Anita R Michael,
Arindam Dasgupta, PhD,
Barry Cherney, PhD,
Bichsa T Tran,
Bo Chi, PhD,
Brien C Fox,
Carla J Lundi,
Caryn M Mcnab,
Cheron M Portee,
Christina C Santos,
Christina V Santos,
Comyar Shoghi,
Cynthia White,
Daniel W Cline,
Davinna Ligons, PhD,
Diane Cvan Leeuwen,
Doan T Nguyen, PharmD,
Donna Ltartaglino Besone,
Dr. Abhijit Raha, PhD,
Dr. Mark J Seaton, PhD,
Esther C Broner, PhD,
Frances Namuswe, PhD,
Gajendiran Mahadevan, PhD,
Haley H Seymour,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Himanshu Gupta, PhD,
Iris C Macinnes,
Jacqueline Mdiaz Albertini,
James M Mason,
James R Fleckenstein,
Jee Chung, PhD,
Jeffrey P Raimondi,
Jennifer Gogley,
Jennifer M Gogley,
Joel Welch, PhD,
John R Myung,
Joseph L Despins, PhD,
Junho Pak,
Ka L Wong,
Kara A Scheibner, PhD,
Karen M Cooper,
Kathleen R Jones, PhD,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kim Lthomas Cruse,
Laura Fontan, MS,
Leonard H Lavi,
Lequita M Mayhew,
Linda M Cheny,
Lynda L Lanning,
Makini Cobourne Duval, PhD,
Marcia B Williams,
Marcus F Yambot,
Maxyne T Lam,
Melkamu Getie Kebtie, PhD,
Michael F Skelly, PhD,
Michelle A Marsh,
Mihaly S Ligmond,
Mike M Rashti,
Mohsen Rajabi Abhari, FDA,
Nicholas Obiri, PhD,
Nicola M Fenty Stewart,
Niraj R Mehta, PhD,
Omotunde O Osunsanmi,
Peter S Diak,
Rebecca Rodriguez,
Richmond K Yip,
Robert C Steyert,
Robert D Tollefsen,
Robert Darius,
Roger F Zabinski,
Rona Leblanc, PhD,
Ronald L Koller,
Ronda Leblanc,
Sarah Arden,
Scott R Nichols, PhD,
Seongeun Cho (Julia), PhD,
Sidney B Priesmeyer,
Sonia R Peterson,
Stephanie Mangigian, MS/OSH, RN,
Steven Fong, MS, PhD,
Sunitha K Rajaram, PhD,
Taichun Qin, PhD,
Tamika White,
Terri L Dodds,
Thao T Kwan,
Thao X Tran,
Uttaniti Limchumroon (Tom),
Xikui Chen (nmi), PhD,
Yumi J Hiramine,
Yvonne C Wilkes
Stanley Au's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2019 | FDA 483 | Pharmaron (Exton) Lab Services LLC - Form 483, 2019-02-01 |
February, 2019 | FDA 483 Response | Pharmaron (Exton) Lab Services LLC - Form 483R, 2019-02-22 |
February, 2018 | FDA 483 | Alturas Analytics, Inc. - Form 483, 2018-02-16 |
December, 2016 | FDA 483 | QPS, LLC - Form 483, 2016-12-16 |
February, 2017 | FDA 483 | Amgen, Inc - Form 483, 2017-02-17 |
February, 2019 | EIR | Pharmaron (Exton) Lab Services LLC - EIR, 2019-02-01 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more